A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

Rockville’s MaxCyte has made its first acquisition in its more than quarter-century of operation. It’s keeping its eyes out ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Indian pharma stocks experienced heavy selling on February 10, influenced by weak earnings and concerns over possible U.S.

Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

Stock analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the specialty ...

Learn more about whether Legend Biotech Corporation or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Janney Montgomery Scott LLC purchased a new position in VanEck Biotech ETF (NASDAQ:BBH – Free Report) during the fourth ...